Bendamustine in combination with high-dose radiotherapy and thalidomide is effective in treatment of multiple myeloma with central nervous system involvement

被引：21
|
作者：
Nahi, Hareth [1 ]
Svedmyr, Erik [1 ]
Lerner, Richard [1 ]
机构：
[1] Karolinska Inst, Dept Med, Stockholm, Sweden
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2014年 / 92卷 / 05期
关键词：
THERAPY; AGENTS;
D O I：
10.1111/ejh.12247
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：454 / 455
页数：2
相关论文
共 46 条
  • [31] High-dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China
    Chen, Cui
    Sun, Peng
    Cui, Juan
    Yan, Shumei
    Chen, Hao
    Xia, Yi
    Bi, Xiwen
    Liu, Panpan
    Wang, Yu
    Yang, Hang
    Nie, Man
    Zhang, Xue-Wen
    Jiang, Wenqi
    Li, Zhi-Ming
    CANCER MEDICINE, 2019, 8 (04): : 1359 - 1367
  • [32] Myelosuppression-sparing treatment of central nervous system nocardiosis in a multiple myeloma patient utilizing a tedizolid-based regimen: a case report
    Matin, Aasiya
    Sharma, Smriti
    Mathur, Pankaj
    Apewokin, Senu K.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (04) : 488 - 492
  • [33] Effect of single agent high-dose methotrexate-related acute kidney injury on length of hospitalization and relative dose intensity in adult patients with central nervous system lymphoma
    Steward, Jennifer S.
    Bullard, Heather M.
    O'Rourke, Timothy J.
    Campbell, Alan D.
    Brinker, Brett T.
    Yost, Kathleen J.
    Vanderwoude, Amy C.
    Scott, William L.
    Kintzel, Polly E.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (07) : 496 - 501
  • [34] High-Dose Chemotherapy With Thiotepa, Busulfan, and Cyclophosphamide and Autologous Stem Cell Transplantation for Patients With Primary Central Nervous System Lymphoma in First Complete Remission
    DeFilipp, Zachariah
    Li, Shuli
    El-Jawahri, Areej
    Armand, Philippe
    Nayak, Lakshmi
    Wang, Nancy
    Batchelor, Tracy T.
    Chen, Yi-Bin
    CANCER, 2017, 123 (16) : 3073 - 3079
  • [35] A polymorphism in NFKB1 is associated with improved effect of interferon-α maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support
    Vangsted, Annette J.
    Klausen, Tobias W.
    Gimsing, Peter
    Andersen, Niels F.
    Abildgaard, Niels
    Gregersen, Henrik
    Vogel, Ulla
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (09): : 1274 - 1281
  • [36] A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer
    Giordano, Antonio
    Kumthekar, Priya U.
    Jin, Qingchun
    Kurt, Busem Binboga
    Ren, Siyang
    Li, Tianyu
    Leone, Jose Pablo
    Mittendorf, Elizabeth A.
    Pereslete, Alyssa M.
    Sharp, Laura
    Davis, Raechel
    DiLullo, Molly
    Tayob, Nabihah
    Mayer, Erica L.
    Winer, Eric P.
    Tolaney, Sara M.
    Lin, Nancy U.
    CLINICAL CANCER RESEARCH, 2024, 30 (21) : 4856 - 4865
  • [37] Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation
    Inamoto, Yoshihiro
    Kurahashi, Shingo
    Imahashi, Nobuhiko
    Fukushima, Nobuaki
    Adachi, Tatsuya
    Kinoshita, Tomohiro
    Tsushita, Keitaro
    Miyamura, Koichi
    Naoe, Tomoki
    Sugiura, Isamu
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (05) : 283 - 286
  • [38] Combination of High-Dose Intravenous Cyclosporine and Plasma Exchange Treatment Is Effective in Post-Transplant Recurrent Focal Segmental Glomerulosclerosis: Results of Case Series
    Demir, Mehmet Emin
    Uyar, Murathan
    Merhametsiz, Ozgur
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (03) : 843 - 849
  • [39] High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry
    Kondo, Eisei
    Ikeda, Takashi
    Izutsu, Koji
    Chihara, Dai
    Shimizu-Koresawa, Risa
    Fujii, Nobuharu
    Sakai, Tomoyuki
    Kondo, Tadakazu
    Kubo, Kohmei
    Kato, Yuichi
    Akasaka, Takashi
    Fukuda, Takahiro
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Suzumiya, Junji
    Suzuki, Ritsuro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (05) : 899 - 905
  • [40] Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary Central Nervous System Lymphoma
    Sterling, Cole H.
    Tsai, Hua-Ling
    Holdhoff, Matthias
    Bolanos-Meade, Javier
    Luznik, Leo
    Fuchs, Ephraim J.
    Huff, Carol Ann
    Gocke, Christian B.
    Ali, Syed Abbas
    Borrello, Ivan M.
    Varadhan, Ravi
    Jones, Richard J.
    Gladstone, Douglas E.
    Ambinder, Richard F.
    Wagner-Johnston, Nina
    Swinnen, Lode J.
    Imus, Philip H.
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 863.e1 - 863.e5
12345